Dachaigh › Galar Crohn › Florida › Orlando
Sgrùdaidhean clionaigeach Galar Crohn ann an Orlando, FL
Tha 17 sgrùdaidhean airson Galar Crohn a’ lorg phàirtichean aig làraichean ann agus timcheall air Orlando (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
A’ fastadhÌre 2
- Digestive And Liver Center Of Florida - Orlando /ID# 280924, Orlando
- Clinical Research of Osceola /ID# 280593, Kissimmee · 16 mìle air falbh
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
A’ fastadhÌre 3
- AdventHealth Orlando ( Site 5131), Orlando
- Endoscopic Research Inc ( Site 5061), Orlando
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
A’ fastadhÌre 4
- Endoscopic Research, Inc., Orlando
- Orlando Health-Orlando Regional Medical Center, Orlando
- Digestive and Liver Center of Florida, P.A., Kissimmee · 16 mìle air falbh
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
A’ fastadhÌre 2
- Endoscopic Research, Inc. /ID# 267211, Orlando
- Novum Research /ID# 278128, Clermont · 24 mìle air falbh
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
A’ fastadhÌre 2
- AdventHealth (Florida Hospital) Medical Group, Orlando
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
A’ fastadhÌre 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
A’ fastadhÌre 3
- AdventHealth Orlando-Site Number: 8400070, Orlando
- Orlando Health, Inc.-Site Number: 8400084, Orlando
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee · 16 mìle air falbh
- agus 1 a bharrachd
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
A’ fastadhÌre 3
- Orlando Health, Inc., Digestive Health Institute-Site Number: 8400084, Orlando
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee · 16 mìle air falbh
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
A’ fastadhÌre 3
- Arnold Palmer Hospital for Children Center Digestive Health and Nutrition-Orland /ID# 255437, Orlando
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
A’ fastadhÌre 2
- Endoscopic Research Inc, Orlando
- Clinical Research of Osceola, Kissimmee · 16 mìle air falbh
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
A’ fastadhÌre 4
- Endoscopic Research Inc, Orlando
- Clinical Research of Osceola, Kissimmee · 16 mìle air falbh
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
A’ fastadh
- Advent Health, Orlando
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
A’ fastadhSgrùdadh amharc
- AdventHealth, Orlando
Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD
A’ fastadhÌre 4
- Digestive & Liver Center of Florida, Orlando
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
A’ fastadhÌre 2
- Orlando Health, Inc., Orlando
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
A’ fastadhÌre 2
- Investigational Site Number: 8400007, Orlando
- Investigational Site Number: 8400017, Kissimmee · 16 mìle air falbh
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
A’ fastadhÌre 2
- Mirador Therapeutics Selected Site, Orlando
Sgrùdaidhean Galar Crohn ann am bailtean eile
- New York City, NY35 sgrùdaidhean
- Boston, MA19 sgrùdaidhean
- Miami, FL19 sgrùdaidhean
- Cleveland, OH19 sgrùdaidhean
- St. Louis, MO19 sgrùdaidhean
- Tyler, TX17 sgrùdaidhean
- Houston, TX17 sgrùdaidhean
- Atlanta, GA17 sgrùdaidhean
- San Antonio, TX15 sgrùdaidhean
- San Diego, CA15 sgrùdaidhean
- Los Angeles, CA15 sgrùdaidhean
- Colorado Springs, CO13 sgrùdaidhean
Sgrùdaidhean eile ann an Orlando
- Aillse Sgamhain Neo-chealla-beag44 sgrùdaidhean
- Obesity32 sgrùdaidhean
- Ailse metastatach29 sgrùdaidhean
- Ro-throm27 sgrùdaidhean
- Galar Alzheimer25 sgrùdaidhean
- Diabaitis Seòrsa 225 sgrùdaidhean
- Aillse (gach seòrsa)24 sgrùdaidhean
- Aillse a' bhroilleach23 sgrùdaidhean
- Cancer Ovarian22 sgrùdaidhean
- Colitis Ulcerative22 sgrùdaidhean
- Ailseachadh nan Sgamhan21 sgrùdaidhean
- Aillse colorectal19 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.